Overview of Imported Monoammonium Phosphate and Triple Superphosphate in Brazil

Brazil imported 4.31 million tons of monoammonium phosphate and 1.26 million tons of triple superphosphate in the first ten months of this year, both reaching record highs.

Monoammonium Phosphate:

In the period from January to October 2023, Brazil imported 4.31 million tons of monoammonium phosphate, showing an 18% year-on-year growth and setting a new record for the same period. Russia remained the largest supplier with a shipment of 1.96 million tons, showing a 28% increase. Morocco's OCP exported 1.27 million tons of monoammonium phosphate to Brazil, showing a growth of over one-third compared to the same period last year. The total shipments from Saudi suppliers Ma'aden and Sabic reached 742,000 tons, showing a 13% year-on-year increase.

However, shipments from the United States and China declined.

From January to October, the U.S. market share in Brazil for monoammonium phosphate remained limited, with Brazil importing 190,000 tons, showing a 36% year-on-year decrease. China's supply to Brazil decreased by 6.75% to 148,000 tons.

In October, Brazil imported a total of 461,000 tons of monoammonium phosphate, slightly lower than September (473,000 tons) but higher than the same period last year (261,000 tons), with OCP and Russian suppliers importing 217,000 tons and 116,000 tons, respectively.

Triple Superphosphate:

Brazil's import of triple superphosphate (TSP) continued to grow at a record pace, reaching 1.26 million tons from January to October, showing a 29% year-on-year increase. Of this, imports from OCP amounted to 646,000 tons, showing an 80% year-on-year increase, and imports from China increased by 44% to reach 213,000 tons. Israel's ICL increased its delivery volume by 12% to reach 154,000 tons.

However, due to trade companies targeting sales in other markets in the European region, imports from Egypt significantly decreased by 45% to 58,000 tons.

NOTE：This article is provided for readers' commercial reference and is not intended as investment advice. Kelewell is not responsible for the accuracy of the data.